πŸ‡ΊπŸ‡Έ FDA
Patent

US 6939971

Benzimidazole compound crystal

expired A61KA61K31/4439A61P

Quick answer

US patent 6939971 (Benzimidazole compound crystal) held by Takeda Pharmaceutical Company Limited expires Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Sep 06 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/4439, A61P, A61P1/00, A61P1/04